Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/165172
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ruiz de Porras, Vicenç | - |
dc.contributor.author | Bystrup, Sara | - |
dc.contributor.author | Cabrero de las Heras, Sara | - |
dc.contributor.author | Musulén, Eva | - |
dc.contributor.author | Palomero, Luis | - |
dc.contributor.author | Alonso Aguado, Maria Henar | - |
dc.contributor.author | Nieto, Rocio | - |
dc.contributor.author | Arango, Diego | - |
dc.contributor.author | Moreno Aguado, Víctor | - |
dc.contributor.author | Queralt, Cristina | - |
dc.contributor.author | Manzano, José Luis | - |
dc.contributor.author | Layos, Laura | - |
dc.contributor.author | Bugés, Cristina | - |
dc.contributor.author | Martínez Balibrea, Eva | - |
dc.date.accessioned | 2020-06-11T15:17:10Z | - |
dc.date.available | 2020-06-11T15:17:10Z | - |
dc.date.issued | 2019-10-11 | - |
dc.identifier.issn | 2072-6694 | - |
dc.identifier.uri | http://hdl.handle.net/2445/165172 | - |
dc.description.abstract | In recent years, an increasing number of studies have shown that elevated expression of cyclin dependent kinase (Cdk5) contributes to the oncogenic initiation and progression of many types of cancers. In this study, we investigated the expression pattern of Cdk5 in colorectal cancer (CRC) cell lines and in a large number of tumor samples in order to evaluate its relevance in this pathogenesis and possible use as a prognostic marker. We found that Cdk5 is highly expressed and activated in CRC cell lines and that silencing of the kinase decreases their migration ability. In tumor tissues, Cdk5 is overexpressed compared to normal tissues due to a copy number gain. In patients with localized disease, we found that high Cdk5 levels correlate with poor prognosis, while in the metastatic setting, this was only the case for patients receiving an oxaliplatin-based treatment. When exploring the Cdk5 levels in the consensus molecular subtypes (CMS), we found the lowest levels in subtype 1, where high Cdk5 again was associated with a poorer prognosis. In conclusion, we confirm that Cdk5 is involved in CRC and disease progression and that it could serve as a prognostic and predictive biomarker in this disease. | - |
dc.format.extent | 17 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/cancers11101540 | - |
dc.relation.ispartof | Cancers, 2019, vol. 11, num. 10, p. 1540 | - |
dc.relation.uri | https://doi.org/10.3390/cancers11101540 | - |
dc.rights | cc-by (c) Ruiz de Porras, Vicenç et al., 2019 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | Càncer colorectal | - |
dc.subject.classification | Marcadors bioquímics | - |
dc.subject.classification | Enzims | - |
dc.subject.other | Colorectal cancer | - |
dc.subject.other | Biochemical markers | - |
dc.subject.other | Enzymes | - |
dc.title | Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 698693 | - |
dc.date.updated | 2020-06-11T15:17:10Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 31614664 | - |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
698693.pdf | 2.47 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License